Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
In vivo screening of S100B inhibitors for melanoma therapyDanna B Zimmer, Rena G Lapidus, David J Weber
Molecules (Basel, Switzerland)|August 31, 2019
Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia ChemotherapeuticsMichelle H Lee, Rena G Lapidus, Dana Ferraris, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 6, 2016
Comparative Analysis of Methods for Detecting Isocitrate Dehydrogenase 1 and 2 Mutations and Their Metabolic Consequence, 2-Hydroxyglutarate, in Different NeoplasmsShahab Babakoohi, Rena G Lapidus, Rawan Faramand, et al.
Advances in Cancer Research|January 30, 2019
Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironmentAksinija A Kogan, Rena G Lapidus, Maria R Baer, et al.
Bioorganic & Medicinal Chemistry|May 3, 2016
Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring systemMin Xie, Rena G Lapidus, Mariola Sadowska, et al.
Oncotarget|October 21, 2017
Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activityMyoung Sook Kim, Ramkishore Gernapudi, Eun Yong Choi, et al.
American Journal of Cancer Research|December 23, 2015
IKK phosphorylation of NF-κB at serine 536 contributes to acquired cisplatin resistance in head and neck squamous cell cancerZhipeng Li, Zejia Yang, Rena G Lapidus, et al.
Biochemical and Biophysical Research Communications|May 26, 2021
A novel XBP1 variant is highly enriched in cancer tissues and is specifically required for cancer cell survivalYongwang Zhong, Wenjing Yan, Jingjing Ruan, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring systemMin Xie, Ravi K Ujjinamatada, Mariola Sadowska, et al.
BMC Cancer|May 24, 2019
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathwayZejia Yang, Jipei Liao, Brandon A Carter-Cooper, et al.
Pageof 7